Table 2.
Estimated mean A1c level and instantaneous linear change in A1c at baseline and 3 and 6 months with group differences and prestudy A1c level as a covariate.a
| Factor | n | Usual care group | Treatment group | Group difference | t-ratio159 b | P | |
| Mean A 1c level, % (mmol/mol) |
|
|
|
|
|
|
|
|
|
Baseline | 90 | 8.16 (66) | 8.46 (69) | 0.30 | 1.57 | .12 |
|
|
3 months | 83 | 7.68 (60) | 7.81 (62) | 0.11 | 0.63 | .53 |
|
|
6 months | 80 | 7.46 (58) | 7.35 (57) | –0.11 | –0.59 | .55 |
| Prestudy A1c effectc |
|
0.52 | — | — | 5.23 | <.001 | |
| Instantaneous linear change in A 1c d |
|
|
|
||||
|
|
Baseline | 90 | –0.62 | –0.80 | –0.18 | –0.94 | .35 |
|
|
3 months | 83 | –0.35 | –0.56 | –0.21 | –1.87 | .06 |
|
|
6 months | 80 | –0.07 | –0.31 | –0.23 | –2.87 | .005 |
| Estimated change from baseline to 6 months |
|
–0.70 | –1.11 | –0.41 |
|
|
|
| Acceleration ratee |
|
0.14 | 0.12 | –0.01 | –0.26 | .80 | |
a Tabled values are maximum-likelihood estimates.
b t-ratios are ratios of the estimates to their respective standard errors.
c The prestudy A1c effect, a regression coefficient, is the change in A1c when measured during the study for a unit increase in prestudy A1c level.
d Instantaneous linear change in A1c reflects the point change in A1c for a 90-day increment.
e Acceleration rate is the rate of acceleration of the quadratic growth model.